Decision: Favourable
Study Title:
Protocol IM026024: A Phase 2, Multicenter, Randomized, Double-blind, PlaceboControlled, Study to Evaluate the Efficacy and Safety of BMS-986256 in Participants with Active Systemic Lupus Erythematosus
NREC Code:
21-NREC-CT-127
Decision:
Favourable
Meeting Date:
03/11/2021
Study Type:
CT application
Principal Investigator:
Dr Trevor Duffy
PI Institution:
Connolly Hospital
Sponsor:
Bristol Myers Squibb International Corporation